Welcome to GENESIS Hangzhou!

page_banner

product

China New Product Antigen Rapid - KaiBiLi COVID-19 Antigen – Genesis


Product Detail

Related Video

Feedback (2)

We always stick to the principle "Quality First, Prestige Supreme". We are fully committed to providing our clients with competitively priced quality products, prompt delivery and professional service for Antigen Rapid Test Swab, Specimen Collection Throat Swab, Specimen Collection Cup, When you are interested in any of our solutions or want to examine a tailor made get, you should really feel absolutely free to speak to us.
China New Product Antigen Rapid - KaiBiLi COVID-19 Antigen – Genesis Detail:

Introduction

COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main symptoms including manifestations include fever, fatigue and dry cough, nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.

The KaiBiLiTM COVID-19 Antigen Rapid Test Device is an in vitro diagnostic test based on the principle of immunochromatography for the qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in nasal swab or nasopharyngeal swab. The detection is based on the antibodies which were developed specifically recognizing and reacting with the nucleoprotein of 2019 Novel Coronavirus. It is intended to aid in the rapid diagnosis of SARS-CoV-2 infection.

This assay is intended for rapid screening in laboratory. This test should be conducted by trained technician, wearing appropriate personal protective equipment (PPE). 

Detection

The qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in nasal swab or nasopharyngeal swab.

Specimen

Nasal or nasopharyngeal 

Limit of Detection (LoD)

2019 Novel Coronavirus: 140 TCID50/mL

ACCURACY (Nasal swab)

Positive Percent Agreement: 96.6%

Negative Percent Agreement:100%

Overall Percent Agreement: 98.9%

ACCURACY(Nasopharyngeal swab)

Positive Percent Agreement: 97.0%

Negative Percent Agreement:98.3%

Overall Percent Agreement: 97.7%

Time to Results

Read results at 15minutes and no more than 30 minutes. 

Kit storage conditions

2~30°C. 

Contents

Description

Qty

COVID-19 antigen test devices

20

Sterilized swabs

20

Extraction tubes (with 0.5mL extraction buffer)

20

Nozzles with filter

20

Tube Stand

1

Package Insert

1

Ordering Information

Product

Cat.No.

Contents

KaiBiLiTM COVID-19 Antigen 

P211139

20 Tests


Product detail pictures:

China New Product  Antigen Rapid - KaiBiLi COVID-19 Antigen – Genesis detail pictures

China New Product  Antigen Rapid - KaiBiLi COVID-19 Antigen – Genesis detail pictures

China New Product  Antigen Rapid - KaiBiLi COVID-19 Antigen – Genesis detail pictures


Related Product Guide:

Innovation, excellent and reliability are the core values of our company. These principles today much more than ever form the basis of our success as an internationally active mid-size business for China New Product Antigen Rapid - KaiBiLi COVID-19 Antigen – Genesis , The product will supply to all over the world, such as: Ecuador, Venezuela, Kenya, Our factory is equipped with complete facility in 10000 square meters, which makes us be able to satisfy the producing and sales for most auto part products. Our advantage is full category, high quality and competitive price! Based on that, our products win a high admiration both at home and abroad.
The customer service staff's answer is very meticulous, the most important is that the product quality is very good, and packaged carefully, shipped quickly!
5 Stars By Eartha from Montreal - 2017.11.01 17:04
We are a small company that has just started, but we get the company leader's attention and gave us a lot of help. Hope we can make progress together!
5 Stars By Gill from Ghana - 2018.06.18 17:25
Write your message here and send it to us